STA-5326 in Crohn's Disease Patients
Public ClinicalTrials.gov record NCT00088062. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/IIa Trial of STA-5326 in Crohn's Disease Patients With CDAI Scores of 220-450
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and tolerability of STA-5326 given once daily or twice daily to Crohn's Disease patients with moderate disease.
Study identification
- NCT ID
- NCT00088062
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Nov 2004 (Type not available)
- Last update posted
- Jun 24, 2005
2004
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Clinical Therapeutics | Tucson | Arizona | 85712 | — |
| Advanced Clinical Research Institute | Anaheim | California | 92801 | — |
| Venture Research Institute, LLC | North Miami Beach | Florida | 33162 | — |
| Shafran Gastoenterology Center | Winter Park | Florida | 32789 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Heart of America Research Institute | Topeka | Kansas | 66614 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02215 | — |
| Long Island Clinical Research | Great Neck | New York | 10021 | — |
| Rochester Institute for Digestive Diseases and Sciences, Inc | Rochester | New York | 14607 | — |
| Carolina Research Associates | Charlotte | North Carolina | 28262 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| West Hills GI | Portland | Oregon | — | — |
| Blair Gastroenterology Associates | Altoona | Pennsylvania | 16602 | — |
| Memphis Gastroenterology Group | Memphis | Tennessee | 38120 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00088062, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00088062 live on ClinicalTrials.gov.